{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:34:01Z","timestamp":1791182041238,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.iac.2014.01.006","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T11:31:27Z","timestamp":1395055887000},"page":"341-355","source":"Crossref","is-referenced-by-count":25,"title":["CD30 in Systemic Mastocytosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Bjorn","family":"van Anrooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne N.G.","family":"Oude Elberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5878","key":"10.1016\/j.iac.2014.01.006_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.iac.2014.01.006_bib2","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the international peripheral T-cell lymphoma project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.iac.2014.01.006_bib3","first-page":"439","volume":"vol. 15","author":"Swerdlow","year":"2008"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","article-title":"Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease","volume":"68","author":"Durkop","year":"1992","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-S","article-title":"CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF","volume":"73","author":"Smith","year":"1993","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.iac.2014.01.006_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jlb.57.5.726","article-title":"CD30 and type 2 T helper (Th2) responses","volume":"57","author":"Romagnani","year":"1995","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy","volume":"85","author":"Falini","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","article-title":"Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis","volume":"24","author":"Sotlar","year":"2011","journal-title":"Mod Pathol"},{"issue":"1\u20132","key":"10.1016\/j.iac.2014.01.006_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-1119(96)00542-2","article-title":"Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene","volume":"182","author":"Aizawa","year":"1996","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0888-7543(05)80203-4","article-title":"Assignment of the human CD30 (ki-1) gene to 1p36","volume":"14","author":"Fonatsch","year":"1992","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib11","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.4049\/jimmunol.139.6.2081","article-title":"Biochemical characterization and biosynthesis of the ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines","volume":"139","author":"Froese","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib12","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1182\/blood.V88.7.2422.bloodjournal8872422","article-title":"A\u00a0variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages","volume":"88","author":"Horie","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/10428190290033288","article-title":"Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family","volume":"43","author":"Schneider","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib14","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.157.8.3635","article-title":"Reverse signaling via CD30 ligand","volume":"157","author":"Wiley","year":"1996","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/0008-5472.CAN-06-2470","article-title":"ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in\u00a0vitro","volume":"67","author":"Eichenauer","year":"2007","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.iac.2014.01.006_bib16","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.4049\/jimmunol.165.12.6703","article-title":"CD30 shedding from karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme","volume":"165","author":"Hansen","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0014-5793(01)03076-9","article-title":"CD30L up-regulates CD30 and IL-4 expression by T cells","volume":"508","author":"Rossi","year":"2001","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1521-4141(200201)32:1<163::AID-IMMU163>3.0.CO;2-T","article-title":"Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30","volume":"32","author":"Hargreaves","year":"2002","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1096\/fj.03-0901fje","article-title":"The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5","volume":"18","author":"Hansen","year":"2004","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20020319","article-title":"Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus","volume":"196","author":"Saraiva","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/jlb.63.6.752","article-title":"Construction and expression of a soluble form of human CD30 ligand with functional activity","volume":"63","author":"Powell","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib22","first-page":"9","article-title":"Human embryonal tissues of all three germ layers can express the CD30 antigen. an immunohistochemical study of 30 fetuses coming after therapeutic abortions from week 8th to week 16th of gestation","volume":"42","author":"Tamiolakis","year":"2006","journal-title":"Cesk Patol"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2567.2006.02354.x","article-title":"Deciphering CD30 ligand biology and its role in humoral immunity","volume":"118","author":"Kennedy","year":"2006","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nri1665","article-title":"Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization","volume":"5","author":"Lane","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib25","first-page":"469","article-title":"CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues","volume":"149","author":"Gruss","year":"1996","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib26","first-page":"187","article-title":"Human macrophages can express the Hodgkin's cell-associated antigen ki-1 (CD30)","volume":"134","author":"Andreesen","year":"1989","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.iac.2014.01.006_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<613::AID-PATH559>3.0.CO;2-0","article-title":"Expression of the CD30 antigen in non-lymphoid tissues and cells","volume":"190","author":"Durkop","year":"2000","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.iac.2014.01.006_bib28","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.4049\/jimmunol.151.5.2380","article-title":"CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells","volume":"151","author":"Ellis","year":"1993","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.iac.2014.01.006_bib29","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1073\/pnas.0437996100","article-title":"Transcriptional analysis of the B cell germinal center reaction","volume":"100","author":"Klein","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.iac.2014.01.006_bib30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.20020881","article-title":"Silencing of B cell receptor signals in human naive B cells","volume":"196","author":"Feldhahn","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.iac.2014.01.006_bib31","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood.V74.5.1678.1678","article-title":"BER-H2: A new anti-ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope","volume":"74","author":"Schwarting","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.165.2.786","article-title":"Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells","volume":"165","author":"Cerutti","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.iac.2014.01.006_bib33","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/eji.200939508","article-title":"NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30-dependent mechanism","volume":"39","author":"Bekiaris","year":"2009","journal-title":"Eur J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.iac.2014.01.006_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/BC-2011-213","article-title":"A\u00a0novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cells","volume":"393","author":"Simhadri","year":"2012","journal-title":"Biol Chem"},{"issue":"10","key":"10.1016\/j.iac.2014.01.006_bib35","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1182\/blood-2005-10-4170","article-title":"Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells","volume":"107","author":"Cattoretti","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.iac.2014.01.006_bib36","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V91.9.3323","article-title":"High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus","volume":"91","author":"Romagnani","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib37","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.4049\/jimmunol.172.4.2186","article-title":"Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in\u00a0vitro","volume":"172","author":"Matsumoto","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.iac.2014.01.006_bib38","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1182\/blood.V88.9.3299.bloodjournal8893299","article-title":"Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line","volume":"88","author":"Pinto","year":"1996","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib39","first-page":"85","article-title":"CD30 (ki-1) molecule expression in human embryonal epithelial cells of the basal layer of the developing epidermis and epidermal buds and its potential significance for embryogenesis","volume":"14","author":"Tamiolakis","year":"2005","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib40","first-page":"276","article-title":"High expression of the CD30 molecule in human decidual cells","volume":"145","author":"Ito","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.iac.2014.01.006_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/978-0-387-89520-8_12","article-title":"Targeting CD30\/CD30L in oncology and autoimmune and inflammatory diseases","volume":"647","author":"Oflazoglu","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/0962935031000097736","article-title":"Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and scoring atopic dermatitis index","volume":"12","author":"Di Lorenzo","year":"2003","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib43","first-page":"279","article-title":"CD30 serum levels and response to hymenoptera venom immunotherapy","volume":"18","author":"Foschi","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000078438","article-title":"Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and graves' disease (Th2)","volume":"11","author":"Phenekos","year":"2004","journal-title":"Neuroimmunomodulation"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib45","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10620-012-2129-0","article-title":"CD30 ligand\/CD30 interaction is involved in pathogenesis of inflammatory bowel disease","volume":"57","author":"Somada","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9343(97)00049-1","article-title":"High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis","volume":"102","author":"Wang","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2014.01.006_bib47","doi-asserted-by":"crossref","unstructured":"Moonim M, Kossier T, van Der Walt J, et\u00a0al. CD30\/CD123 expression in systemic mastocytosis does not correlate with aggressive disease. Poster presented at: 54th Annual Meeting of the American Society of Hematology. Atlanta, GA, December 8, 2012.","DOI":"10.1182\/blood.V120.21.1746.1746"},{"key":"10.1016\/j.iac.2014.01.006_bib48","first-page":"324A","article-title":"Subtypes of systemic mastocytosis exhibit distinct immunomorphologic features in bone marrow biopsies","volume":"93","author":"Chiu","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.iac.2014.01.006_bib49","first-page":"285A","article-title":"CD30 expression in mastocytosis","volume":"91","author":"Arredondo","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.iac.2014.01.006_bib50","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"312","article-title":"Anaplastic large cell lymphoma (ALCL), ALK-positive","author":"Delsol","year":"2008"},{"issue":"14","key":"10.1016\/j.iac.2014.01.006_bib51","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the international DLBCL rituximab-CHOP consortium program study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"3 Pt 1","key":"10.1016\/j.iac.2014.01.006_bib52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/jid.2011.351","article-title":"High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides","volume":"132","author":"Kadin","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib53","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1182\/blood.V91.8.3011.3011_3011_3016","article-title":"Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome","volume":"91","author":"Nadali","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.iac.2014.01.006_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0609.2006.00725.x","article-title":"Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis","volume":"77","author":"Visco","year":"2006","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib55","first-page":"1123","article-title":"Classical Hodgkin's disease. clinical impact of the immunophenotype","volume":"151","author":"von Wasielewski","year":"1997","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib57","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.5858\/2001-125-1036-CEIFL","article-title":"CD30 expression in follicular lymphoma","volume":"125","author":"Gardner","year":"2001","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"10.1016\/j.iac.2014.01.006_bib58","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","article-title":"Primary mediastinal B-cell lymphoma: High frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins","volume":"162","author":"Pileri","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/002215540205000216","article-title":"CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma","volume":"50","author":"Leroy","year":"2002","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ajcp\/105.2.221","article-title":"Primary body cavity-based AIDS-related lymphomas","volume":"105","author":"Ansari","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib62","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","article-title":"CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis","volume":"63","author":"Morgado","year":"2013","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clml.2012.12.006","article-title":"CD30 expression in high-risk acute myeloid leukemia and myelodysplastic syndromes","volume":"13","author":"Zheng","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"10.1016\/j.iac.2014.01.006_bib64","first-page":"939","article-title":"Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK\/T-cell lymphoma, nasal type","volume":"5","author":"Hong","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib65","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2559.1995.tb00272.x","article-title":"CD30 (ki-1) expression in adult T-cell leukaemia\/lymphoma is associated with distinctive immunohistological and clinical characteristics","volume":"26","author":"Takeshita","year":"1995","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.iac.2014.01.006_bib67","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1349-7006.2005.00106.x","article-title":"Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia\/lymphoma","volume":"96","author":"Nishioka","year":"2005","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.1711680311","article-title":"High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas","volume":"168","author":"Kanavaros","year":"1992","journal-title":"J\u00a0Pathol"},{"issue":"4\u20135","key":"10.1016\/j.iac.2014.01.006_bib69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/10428199309148529","article-title":"Tumor viruses in CD30-positive anaplastic large cell lymphomas","volume":"9","author":"Herbst","year":"1993","journal-title":"Leuk Lymphoma"},{"issue":"Suppl 4","key":"10.1016\/j.iac.2014.01.006_bib70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/7.suppl_4.S11","article-title":"The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease","volume":"7","author":"Niedobitek","year":"1996","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib71","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1182\/blood-2002-11-3507","article-title":"MEK\/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival","volume":"102","author":"Zheng","year":"2003","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.iac.2014.01.006_bib72","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.molimm.2009.05.178","article-title":"TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells","volume":"46","author":"Guo","year":"2009","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2008.070858","article-title":"CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells","volume":"172","author":"Hirsch","year":"2008","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.leukres.2005.08.010","article-title":"mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma","volume":"30","author":"Staber","year":"2006","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ijc.2910600419","article-title":"Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (ki-4)","volume":"60","author":"Horn-Lohrens","year":"1995","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-065X.2011.01057.x","article-title":"OX40 and CD30 signals in CD4(+) T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4(+) T-cell memory but not effector function","volume":"244","author":"Withers","year":"2011","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib77","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.174.7.3891","article-title":"Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory","volume":"174","author":"Gaspal","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib78","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/eji.1830250805","article-title":"Regulation of murine B cell growth and differentiation by CD30 ligand","volume":"25","author":"Shanebeck","year":"1995","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.iac.2014.01.006_bib79","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/eji.200839004","article-title":"Different role of CD30 in the development of acute and chronic airway inflammation in a murine asthma model","volume":"39","author":"Polte","year":"2009","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/intimm\/dxm130","article-title":"CD30 supports lung inflammation","volume":"20","author":"Nam","year":"2008","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.iac.2014.01.006_bib81","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/eji.201141423","article-title":"The central role of CD30L\/CD30 interactions in allergic rhinitis pathogenesis in mice","volume":"41","author":"Fuchiwaki","year":"2011","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.iac.2014.01.006_bib82","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02977.x","article-title":"Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease","volume":"114","author":"Molin","year":"2001","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.iac.2014.01.006_bib83","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1172\/JCI24274","article-title":"Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion","volume":"116","author":"Fischer","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.iac.2014.01.006_bib84","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/0008-5472.CAN-03-1337","article-title":"CD30 is involved in inhibition of T-cell proliferation by Hodgkin's Reed-Sternberg cells","volume":"64","author":"Su","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.iac.2014.01.006_bib85","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/84254","article-title":"Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells","volume":"2","author":"Cerutti","year":"2001","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib86","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaci.2006.07.014","article-title":"Direct evidence for a critical role of CD30 in the development of allergic asthma","volume":"118","author":"Polte","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2014.01.006_bib87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1398-9995.1990.tb00945.x","article-title":"Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa","volume":"45","author":"Muller","year":"1990","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2014.01.006_bib88","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"issue":"1","key":"10.1016\/j.iac.2014.01.006_bib89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases the risk of hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"van Anrooij","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2014.01.006_bib90","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood-2007-07-099317","article-title":"A\u00a0phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies","volume":"111","author":"Bartlett","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.iac.2014.01.006_bib91","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1200\/JCO.2006.07.8972","article-title":"Phase I\/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma","volume":"25","author":"Ansell","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.iac.2014.01.006_bib92","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","article-title":"Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas","volume":"363","author":"Younes","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.iac.2014.01.006_bib93","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1158\/1078-0432.CCR-12-1803","article-title":"U.S. food and drug administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma","volume":"18","author":"de Claro","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856114000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856114000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T06:48:05Z","timestamp":1689058085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856114000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0889856114000071"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2014.01.006","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}